Department: Market Access

Manager, Market Access


The Manager, Market Access will be responsible for global and country market research, market intelligence, monitoring & impact measurement, forecasting, and managing select country relationships.

The role is broad in scope, with involvement in both the pediatric and adult markets, both demand and supply side initiatives, public health and the private sector markets and scope of the work will be at global as well country level. The role will contribute significantly to rapid introduction and broad access to novel TB treatments, developed by TB Alliance.

The Market Access function at the TB Alliance includes all elements on the value chain including supplier relationship management, pricing strategy, forecasting, market understanding, resource mobilization, support for policy change, regulatory issues, diagnostics as well as technical adoption-related issues. 

The opening is happening at an exciting time for new TB regimens. Regulatory approval for a novel, short, all-oral regimen for XDR-TB has recently been obtained, and work is ongoing to support planning for a forthcoming short regimen for both DS and MDR-TB.

Position description:

  • Keep abreast of market trends and developments in the field of TB and ensure TB Alliance has contemporary and in-depth market intelligence and understanding of the TB market and sub-segments, to help guide strategies for adoption and uptake of new TB regimens
  • Design, guide and coordinate market research to support and inform policy development, global, regional and country launch planning and market uptake initiatives
  • Develop forecasts for TB medicines and regimens in collaboration with global stakeholders
  • Monitor, measure and report uptake of medicines and regimens developed by TB Alliance, and impact created by them
  • Provide guidance into market analytics and data to help inform development of novel TB treatments
  • Manage select country relationships and guide implementation of strategy in close coordination with commercial partners
  • Help develop strategies and interventions for select target countries to support access, availability and adoption of forthcoming TB regimens
  • Responsible for compliance with applicable GxP regulations in performing the functions of the job, including attendance at annual GxP or other applicable regulatory trainings provided by TB Alliance.

Ideal candidates will have:

  • A minimum of 5 to 8 years’ professional experience in the following: access to medicines, product introduction, market research, monitoring & evaluation in global health, and forecasting with focus on developing countries
  • Relevant educational background; MBA, MPH or other relevant advanced degree required
  • Experience of working with global health stakeholders as well as the pharmaceutical industry is desirable
  • Working knowledge of current TB treatment landscape in TB endemic countries highly preferred
  • Experience designing primary qualitative and quantitative market research, selecting, commissioning, and overseeing externally conducted research, and experience with resourceful utilization of secondary research to solve challenging business or public health issues
  • Demonstrated ability to rapidly adjust to and take on new areas, and to absorb and synthesize a broad range of information, especially clinical and scientific information
  • Ability to think strategically, handle ambiguity, problem solve
  • Excellent project management, communication and analytical skills
  • Commitment to global health and neglected diseases, specifically TB.


New York, NY

Organizational Information:

TB Alliance is a not-for-profit organization dedicated to the discovery and development of better, faster, affordable tuberculosis drugs that are available to those who need them.Through innovative science and with partners around the globe, we lead a global effort to ensure development of and equitable access to faster, better tuberculosis cures that will advance global health and prosperity.

With an annual operating budget of approximately $60 million, the TB Alliance leads the advancement of the most comprehensive R&D portfolio of TB drug candidates in history. Additionally, the TB Alliance drives efforts to ensure regulatory approval, country adoption of new regimens, and widespread availability of new drug regimens to patients. For more information, please access the website:

Our Pipeline

TB Alliance manages the largest pipeline of new TB drugs in history.

View the portfolio